SpinalCyte Receives New Australian Patent

SpinalCyte was issued Australian Patent No. 2013299505, “Generation of Cartilage Ex Vivo from Fibroblasts.”

The patent addresses use of mechanical stress in an ex vivo, low oxygen environment to produce chondrocytes that support cartilage regrowth. The patent also covers an imaging device to design and develop a mold upon which new...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us